Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.
Research Area · Signal Transduction
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008646 |
1,2- |
30403-47-5 | >95% |
|
2007-08-29 | 4.679074585635 | 1-2-dihexanoyl-sn-glycerol | PKCs second messengers diacylglycerols DAG 1,2-dioctanoyl-sn-glycerols proteins kinases snglycerol | |||
| 10008648 |
1,2- |
30334-71-5 | >95% |
|
2008-06-25 | 4.277969613259 | 1-2-dipalmitoyl-sn-glycerol | NSC 269964; 1,2-DPG | PKC proteins kinases C DAG activator | ||
| 13532 |
17- |
- | ≥98% |
|
✓ | 2010-05-04 | 0E-12 | 17-phenyl-trinor-prostaglandin-e2-ethyl-amide | 17-phenyl trinor PGE2 ethyl amide | 17-phenyl trinor PGE2 agonists EP1 EP3 receptors EP4 smooth muscles contraction fertility prostaglandins PGs | |
| 13812 |
17β- |
- | ≥98% |
|
✓ | 2010-05-18 | 8.609447513812 | 17-hydroxy-wortmannin | phosphoinositide 3-kinase PI3K mTOR inhibitors inhibits inhibition inhibitory cancers 17-hydroxywortmannins 17-hydroxy wortmannins hydroxywortmannins PI3-K HWT phosphatidylinositol | ||
| 13330 |
1- |
221244-14-0 | ≥95% |
|
2009-07-22 | 9.096629834254 | 1-nm-pp1 | PP1 Analog II | inhibitors inhibits inhibition kinases mutated analogs sensitive v-Src vSrc c-Fyn cFyn CDK2 CAMKII mammalian yeast 1NMPP1 | ||
| 10007072 |
1- |
26662-95-3 | ≥98% |
|
2005-12-20 | 12.212217837411 | 1-palmitoyl-2-linoleoyl-pe | PLPE; Phosphatidyl Ethanolamine (1-palmitoyl, 2-linoleoyl) | phosphoethanolamines phosphatidylethanolamines lipids biosynthesis lysophospholipases anandamides biochemical pathways fatty acids cellular membranes A2 D substrates sPLA2-IIA | ||
| 10008650 |
1- |
65914-84-3 | >95% |
|
2008-04-04 | 5.289143646408 | 1-stearoyl-2-arachidonoyl-sn-glycerol | SAG | signal transduction PKCs DAGs .omega.6 PUFA RasGRP ERK MAPK fatty acids signalling signaling activators diacylglycerols | ||
| 10009872 |
1- |
- | ≥99% deuterated product |
|
✓ | 2008-12-04 | 3.077817679558 | 1-stearoyl-2-arachidonoyl-sn-glycerol-d8 | SAG-d8 | deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry deuterated | |
| 10005707 |
(2S)- |
- | >98% |
|
2005-10-19 | 16.667032359904 | -2s-ompt | GPR lysophosphatidic acids lipids mediators receptors LPA1/Edg-2 LPA2/Edg-4 LPA3/Edg-7 LPA4/GPR23 agonists calcium mobilization Sf9 cells (2R)-OMPT release assays LPA3-transfected rat hepatoma Rh7777 | |||
| 10009804 |
3- |
- | ≥98% |
|
2009-03-20 | 10.294672454617 | 3-pt-ptdins-3-4-5-p3-1-2-dioctanoyl-sodium-salt | 3-Phosphorothioate-Phosphatidylinositol-4,5-diphosphate C-8 (sodium salt) | 3-PT-PtdIns(3,4,5)-P3 PtdIns(3,4,5)-P3 PTEN PIP PIP(3,4,5) cells signaling PI3 kinases cancers phosphatidyl inositols phosphates membrane phospholipids signalling sodium transport | ||
| 10010375 |
5- |
24386-93-4 | >95% |
|
2008-01-24 | 1.606077348066 | 5-iodotubercidin | Itu; NSC 113939 | adensosine glycogen hepatocytes phosphorylase .alpha. glycogen synthase .alpha. kinases protein kinase A casein kinases II casein kinases I protein kinase C phosphorylase kinases EFK2 MAPK1 cell proliferations fatty acid oxidations lipogenesis acetyl-CoA carboxylase | ||
| 10009856 |
7- |
- | 2008-10-29 | 14.545303867403 | 7-aad-cell-viability-assay-kit | 7-Amino Actinomycin D Cell Viability Kit | kits 7AAD measurement cells fixation blocking cytoxicity effects environmental toxins drug fluorescence fluorescent cell-based assays cell based assay cba | ||||
| 9000530 |
7(Z)- |
63623-49-4 | ≥98% |
|
2009-12-03 | 39.777316356034 | 7-z-pentacosene | pheromones fruits flies Drosophilia copulation hydrocarbon 7-pentacosene (Z)-7-pentacosene cis-7-pentacosene 7-cis-pentacosene | |||
| 9000313 |
7(Z)- |
52078-42-9 | ≥98% |
|
✓ | 2009-03-15 | 3.781767955801 | 7-z-tricosene | fruits fly flies pheromone drosophila bombus hydrocarbon | ||
| 10010109 |
8- |
- | ≥98% |
|
2008-10-23 | 681.100662983425 | 8-dy547-cgmp | CNGA2 channels activators fluorescences cyclic nucleotides | |||
| 13297 |
AG- |
118409-62-4 | ≥95% |
|
2009-07-14 | 4.803360957642 | ag-126 | Tyrphostin AG-126 | tyrphostins proteins tyrosine inhibitors inhibits inhibition cells growth epidermal growth factors receptors kinase GFRK EGFs EGFRK PDGF PDGFRK platelet-derived platelet derived phosphorylation ERK1 p44 ERK2 p42 TNF-α TNFα TNF α NF-κB NFκB NF κB COX-2 COX2 iNOS inflammation | ||
| 10010568 |
AG- |
134036-53-6 | >95% (cis/trans mixture) |
|
2009-01-09 | 4.299696132596 | ag-370 | NSC 651712 | PTK inhibitor tyrphostin tyrosine PDGF receptor kinase EGF receptor antiproliferative | ||
| 10010243 |
AG- |
149092-50-2 | >98% |
|
2008-01-24 | 3.442991925201 | ag-825 | Tyrphostin AG-825 | Her-2 Her-2/neu erbB tyrosine kinases EGF EGFR cancers anti-cancer prostate breast signal transduction inhibitors inhibition inhibits AG825 AG 825 | ||
| 13735 | Akt2/3 Polyclonal Antibody | - |
|
2010-01-12 | 44.047180566517 | akt2-3-polyclonal-antibody | Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI3-kinase cancers Western blots blotting immunoblotting WB Akt-3 Akt 3 2-3 | ||||
| 13734 | Akt2 Monoclonal Antibody (Clone 95C567.1.2) | - |
|
2010-01-12 | 44.047180566517 | akt2-monoclonal-antibody-clone-95c567-1-2 | Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI#-kinase cancers Western blots blotting immunoblotting WB | ||||
| 10010079 | Akt (human recombinant) Western Ready Control Exclusive | - | ✓ | 2008-08-26 | 17.033922651933 | akt-human-recombinant-western-ready-control | Protein Kinase B; PKB; AKT1 | western blots proteins antibodies antiserum antisera WB kinases serine threonine hexahistidine his-tag his-tagged N-terminal immunoblotting blotting | |||
| 10007466 |
Arachidonic Acid- |
- | >98% |
|
2005-11-30 | 23.604327808471 | arachidonic-acid-biotin | fatty acids PUFAs polyunsaturated biotinylated affinity probes binding proteins cellular cells esterified membranes phospholipids regulated pathways substrates biosynthesis eicosanoids messengers receptor-stimulated release metabolisms re-uptake signalling inflammation detection detected complexes elucidations transports FABPs biotins biotinylated | |||
| 13495 | ARAP2 Polyclonal Antibody | - |
|
2009-09-03 | 0.444113897152 | arap2-polyclonal-antibody | Centaurin-δ-1 | antibodies proteins A chromatography WB western blots immunoblotting IHC immunohistochemistry blotting | |||
| 13496 |
AROS Polyclonal Antibody (aa 1- |
- |
|
2009-09-03 | 0E-12 | aros-polyclonal-antibody-aa-1-50 | WB western blots immunoblotting protein nucleolar RPS19 cDNA chromosome 22q13.1 antibodies blotting | ||||
| 13498 |
ARRB2 Peptide Affinity- |
- |
|
2009-09-22 | 0E-12 | arrb2-peptide-affinity-purified-polyclonal-antibody | β-Arrestin-2 | WB IHC western blots blotting immunoblotting antibodies immunohistochemisty ARRB-2 βarrestin2 β-arrestin2 β arrestin 2 β2R receptors adrenergic | |||
| 13622 |
AS- |
1146702-72-8 | ≥98% |
|
✓ | 2010-01-25 | 42.766114180479 | as-041164 | phosphoinositides 3-kinases PI3K cells growth migration metabolism inhibitors inhibits PI3Kα PI3Kβ PI3Kγ PI3Kδ chemotaxis inflammation neutrophils AS041164 AS-041164 RANTES | ||
| 10009052 |
AS- |
900515-16-4 | >95% |
|
2007-01-30 | 67.745901557006 | as-252424 | phosphoinositides 3-kinases PI-3 PI3-K Phosphatidylinositol inhibitors PI3K .gamma. inhibition inhibitory PtdIns AS252424 | |||
| 10007707 |
AS- |
648450-29-7 | >98% |
|
2007-06-13 | 30.941588249802 | as-605240 | phosphoinositide 3-kinases PI3-kinase PI3-K PI3K phosphoinositide phosphatidylinositols inibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240 | |||
| 10009410 |
ATF2 (Phospho- |
- | 2006-11-28 | 0.814917127071 | atf2-phospho-ser490-498-polyclonal-antibody | Activating Transcription Factor 2 | wb western blotting blots ihc immunohistochemistry antibodies activating transcriptional factors CRE-BP1 AP-1 DNA response elements ATF/CREB leucine zipper proteins regulating regulation genes cytokines cells cycles controls apoptosis death cellular stress inflammatory UV irradiation activity phosphorylation serines brains substrates neuronal neurons growth differentiation human depression phospho-specific immunoblotting | ||||
| 600140 | Autophagy/Cytotoxicity Dual Staining Kit | - |
|
2009-07-14 | 90.794762430939 | autophagy-cytotoxicity-dual-staining-kit | assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis | ||||
| 10011336 |
Avenanthramide- |
955382-52-2 | ≥95% |
|
✓ | 2009-06-18 | 59.635226519337 | avenanthramide-c-methyl-ester | Inhibitors NF-κB IL-6 IL-8 MCP-1 IκB inhibits inhibition Interleukins | ||
| 13813 | Axitinib New | 319460-85-0 | 98% |
|
2010-08-09 | 0E-12 | axitinib | AG 013736 | tyrosine kinases inhibitors inhibition inhibits VEGF VEGFR-1 VEGFR-2 VEGFR-3 c-kit PDGFR-β angiogenesis cancers tumors 790713-39-2 receptors RTKs | ||
| 10011131 |
BAY- |
256498-66-5 | ≥98% |
|
✓ | 2009-11-16 | 21.306701657458 | bay-41-8543 | soluble guanylate cyclase sGC nitric oxide NO GTP cyclic GMP cGMP agonist stimulator platelet aggregation blood pressure bleeding time thrombosis pulmonary hypertension BAY 41-8543 BAY 41 8543 | ||
| 10011135 |
BAY- |
439083-90-6 | ≥98% |
|
2009-03-13 | 50.968139963168 | bay-60-7550 | inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase | |||
| 13123 | BIO | 667463-62-9 | ≥98% |
|
2009-06-09 | 34.701210226351 | bio | GSK 3 IX; MLS 2052 | GSK-3α GSK-3β inhibitors Cdk cells cycle wnt ESCs differentiation embryonic stem GSK-3a/b GSK3a/b | ||
| 10005836 |
bis(7)- |
224445-12-9 | >98% |
|
2005-04-15 | 2.029171270718 | bis-7-tacrine | 1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydro-acridine | dimeric congeners amino acridines inhibits inhibitors inhibition acetylcholinesterases Alzheimer's disease hydrogen peroxides apoptosis pheochromocytoma cells neurochemistry neuroscience | ||
| 13298 | Bisindolylmaleimide I | 133052-90-1 | ≥95% |
|
2009-08-28 | 21.065524861878 | bisindolylmaleimide-i | Gö 6850; GF 109203X; BIM | 634199-82-9 682340-45-0 inhibitors inhibits inhibitions PCK GSK-3 GSK3 staurosporine 5-HT3 receptors 5HT3 Go 6850 | ||
| 13299 | Bisindolylmaleimide IV | 119139-23-0 | ≥98% |
|
2009-07-29 | 16.360914561957 | bisindolylmaleimide-iv | Arcyriarubin A | PKC PKA staurosporine inhibitors 634199-73-8 | ||
| 13186 |
(±)- |
674289-55-5 | ≥98% |
|
2009-06-09 | 3.006464088398 | -blebbistatin | inhibitors muscles myosin ATPase smooth bleb apoptosis cells migration chemotaxis cytokinesis division growth UV lights | |||
| 10007518 | Capsazepine | 138977-28-3 | >98% |
|
2006-03-29 | 16.283858195212 | capsazepine | vanilloid receptors 1 VR1 transient potential TRP endogenous stimuli tissues injury inflammation pain antagonists capsaicin Ca2+ neonatal rats dorsal root ganglias Chinese hamsters ovary ovaries cells | |||
| 13702 |
Cav1.2 Calcium Channel Monoclonal Antibody (Clone S57- |
- | 2009-11-05 | 1.845323741007 | cav1-2-calcium-channel-monoclonal-antibody-clone-s57-46 | antibodies western blotting blots immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC channels ions fusion proteins gated voltage-gated ligand-gated voltage ligand | |||||
| 13703 |
Cav1.3 Calcium Channel Monoclonal Antibody (Clone S38- |
- | 2009-11-05 | 0.369064748201 | cav1-3-calcium-channel-monoclonal-antibody-clone-s38-8 | antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand | |||||
| 13700 |
Cavβ1 Calcium Channel Monoclonal Antibody (Clone S7- |
- | 2009-10-24 | 0.369064748201 | cav-1-calcium-channel-monoclonal-antibody-clone-s7-18 | antibodies western blotting immunoblotting WB IHC ICC IF immunohistochemistry immunocytochemistry immunofluorescence perox ions channels membrane proteins voltage ligands gated | |||||
| 13701 |
Cavβ4 Calcium Channel Monoclonal Antibody (Clone S10- |
- | 2009-11-05 | 0.369064748201 | cav-4-calcium-channel-monoclonal-antibody-clone-s10-7 | western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels antibodies epilepsy IGE JME subunits gated voltage-gated ligand-gated ligand voltage | |||||
| 10009078 | CAY10505 | 328960-84-5 | ≥98% |
|
2009-11-04 | 10.900440805051 | cay10505 | phosphoinositide 3-kinase immunity autoimmune inflammation PI3Kγ PI3Kα PI3Kβ PI3Kδ casein kinases 2 CK2 phosphorylation PKB/Akt macrophages neutrophil recruitment cancer PI3s T2Ds PI3Ks PI3K.gamma. PI3Kg | |||
| 10010043 | CAY10561 Exclusive | 933786-58-4 | >98% |
|
✓ | 2008-03-06 | 4.249723756906 | cay10561 | Pyrazolylpyrrole ERK Inhibitor | MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors | |
| 10010233 | CAY10567 | 32387-96-5 | >98% |
|
2008-05-06 | 5.657154696132 | cay10567 | BML-257 | Akt1 inhibitors inhibits inhibition translocations HCV hepatitis signal transduction signaling signalling | ||
| 10010400 | CAY10571 | 152121-46-5 | >95% |
|
2008-08-11 | 0E-12 | cay10571 | MAPK signal transduction p38 kinases heat shock cytokines inflammation immuno response CSAID CSBP UL-1 IL1 5-LO 5LO | |||
| 10011247 | CAY10574 | 140651-18-9 | >95% |
|
2008-09-04 | 14.638066298342 | cay10574 | CDK2 cyclin E CDK9 inhibitors inhibits inhibition anticancer cell cycle CAN508 | |||
| 10011248 | CAY10575 | 916985-21-2 | ≥95% |
|
2008-09-03 | 30.749715864245 | cay10575 | IKKε IKK-ε IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition NF-κB | |||
| 10011256 | CAY10577 | 300675-28-9 | ≥95% |
|
2008-09-02 | 0.397790055249 | cay10577 | inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers | |||
| 10011264 | CAY10578 | 19231-60-8 | ≥95% |
|
2008-08-26 | 0.397790055249 | cay10578 | inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids | |||
| 13206 | CAY10593 Exclusive | - | ≥95% |
|
✓ | 2009-09-03 | 18.976316758748 | cay10593 | VU0155069 | inhibitors inhibits inhibitions phospholipases D PLD PLD1 PLD2 phosphatidic acids PAs chemotaxis cells migration cancers breast lines tumors trans well assays 1130067-06-9 | |
| 13207 | CAY10594 Exclusive | 1130067-34-3 | ≥98% |
|
✓ | 2009-06-23 | 14.367145488029 | cay10594 | Phospholipase D PLDs PLD1 PLD2 phosphatidic acid PA inhibitors chemotaxis cells migration cancers breast cancer inhibition inhibited | ||
| 13281 | CAY10598 Exclusive New | 346673-06-1 | ≥98% |
|
✓ | 2010-05-07 | 28.830165745856 | cay10598 | Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection | ||
| 13358 | CAY10608 Exclusive New | 457897-92-6 | ≥98% |
|
✓ | 2010-04-29 | 0E-12 | cay10608 | N-Methyl-D-aspartate NMDA receptors antagonists glutamate glycine propanolamine NR2B subunit AMPA kainate neuroprotection neurochemistry antagonizes potently selectively non-competitively | ||
| 13838 | CAY10626 Exclusive New | 1202884-94-3 | ≥98% |
|
✓ | 2010-08-23 | 0E-12 | cay10626 | PI3Kα mTOR cancers signal transduction inhibitors inhibits inhibition phosphatidylinositol 3-kinase PtdIns PIs | ||
| 10010350 |
CCG- |
285986-88-1 | >98% |
|
✓ | 2007-09-20 | 7.144751381215 | ccg-1423 | Rho signaling transduction cancers proliferations anti-proliferation anti-tumor serum response factor GTPase inhibits inhibitors inhibition signalling | ||
| 13322 | CGP 57380 | 522629-08-9 | ≥95% |
|
2009-08-28 | 19.170635359116 | cgp-57380 | MNK1 Inhibitor | inhibitors inhibits inhibitions MAPKs MAP kinases interacting interacting-kinase 1 MNK1 p38 JNK1 ERK1/2 PKC Src-like phosphorylation elF4E TNF-a TNF-α TNFα TNFa arsenite anisomycin PMA fetal calf serum 293 cells RAW264.7 toll-like receptors TLR2 HKLM TLR4 LPS TLR6/2 FSL TLR7 imiquimod TLR9 CpG DNA CGP57380 CGP-57380 | ||
| 13686 | Chidamide New | 743420-02-2 | ≥98% |
|
2010-08-10 | 105.360761291519 | chidamide | HDACs histones deacetylase H3 acetylation colon cancers cells inhibitors inhibits inhibiton LoVo HT-29 HT29 HT 29 | |||
| 13305 | D 4476 | 301836-43-1 | ≥98% |
|
2009-07-29 | 22.899686924493 | d-4476 | Casein Kinase I Inhibitor | inhibitors inhibits inhibition casein kinases 1 CK1 Ck1δ TGF-β TGFβ type-1 receptors ALK5 PKD1 p38α MAPK kinases phosphorylation FOXO1a RhoB p53 Smad3 D4476 | ||
| 10010706 |
(−)- |
522-17-8 | >98% |
|
2008-09-18 | 1.759668508287 | -deguelin | (-)-cis-Deguelin | rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K | ||
| 10007945 |
D- |
764-22-7 | ≥98% |
|
2010-08-10 | 0E-12 | d-erythro-sphinganine | D-erythro-Dihydrosphingosine | ceramide sphingosine sphingosine kinases sphinganine-1-phosphates mycotoxins fumonisins cancers protein kinase C PKC spingosine-1-phosphates cell signaling octadecasphinganine Dihydro-C18-sphingosine SPC 102860 SPC102860 signalling SPC-102860 | ||
| 10007903 |
D- |
6918-49-6 | ≥98% |
|
2008-11-21 | 16.293462246777 | d-erythro-sphingosine-c-20 | sphingosines sphingolipids ceramides C-18 C18 C20 gangliosides brain development neurodegenerations | |||
| 10012577 | Diallyl Trisulfide | 2050-87-5 | ≥98% |
|
2009-04-07 | 2.760220994474 | diallyl-trisulfide | DATS; NSC 651936 | garlic hydrogen sulfides H2S cancers tumors smooth muscle cholesterol atherosclerosis donors supresses colon synthesis genes expression adenocarcinomas HCT-15 cells PC-3 xenografts | ||
| 10008448 |
D- |
- | >98% |
|
2007-06-22 | 2.826719613259 | d-myo-inositol-1-2-3-4-tetraphosphate-sodium-salt | Ins(1,2,3,4)-P4 (sodium salt); 1,2,3,4-IP4 (sodium salt) | phosphates IP3 transduction InsPs phosphatidylinositols phospholipases C Pleckstrin homology PH domains signalling signaling cells | ||
| 10008449 |
D- |
- | >98% |
|
2007-06-27 | 4.017592738752 | d-myo-inositol-1-2-3-5-tetraphosphate-sodium-salt | Ins(1,2,3,5)-P4 (sodium salt); 1,2,3,5-IP4 (sodium salt) | inositols phosphates IP3 transduction InsP phosphatidylinositol phospholipase C Pleckstrin signaling signalling cells homology PH domains | ||
| 10008450 |
D- |
- | >98% |
|
2007-06-22 | 3.204396211523 | d-myo-inositol-1-2-3-6-tetraphosphate-sodium-salt | Ins(1,2,3,6)-P4 (sodium salt); 1,2,3,6-IP4 (sodium salt) | inositols phosphates IP3 transduction InsP phosphatidylinositol phospholipases C Pleckstrin homology PH domains signalling signaling cells | ||
| 10008452 |
D- |
- | >98% |
|
2007-06-08 | 7.571933701657 | d-myo-inositol-1-2-4-5-6-pentaphosphate-sodium-salt | 1,2,4,5,6-IP5 (sodium salt); Ins(1,2,4,5,6)P5 (sodium salt) | IP3 inositols phosphate transduction InsP phosphitidylinositol phospholipase C PLC InsP6 kinase signaling signalling cells | ||
| 10008451 |
D- |
- | >98% |
|
2007-06-22 | 3.745390686660 | d-myo-inositol-1-2-4-5-tetraphosphate-sodium-salt | 1,2,4,5-IP4 (sodium salt); Ins(1,2,4,5)P4 (sodium salt) | phosphates IP3 transduction InsPs phosphatidylinositols phospholipases C Pleckstrin homology PH domains signalling signaling cells | ||
| 10008444 |
D- |
- | >98% |
|
2007-06-06 | 3.715840568271 | d-myo-inositol-1-2-5-6-tetraphosphate-sodium-salt | 1,2,5,6-IP4 (sodium salt); Ins(1,2,5,6)P4 (sodium salt) | inositol phosphates IP3 signals transductions InsP phosphitidylinositols phospholipases C PLC Grp-1 Pleckstrin homology PH domain signalling signaling cells | ||
| 10007780 |
D- |
- | >98% |
|
2006-01-13 | 6.725667858303 | d-myo-inositol-1-2-6-triphosphate-sodium-salt | 1,2,6-IP3 (sodium salt); Ins(1,2,6)P3 (sodium salt) | phosphates IP3 signals transductions InsP phosphitidylinositols phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels D/L racemic Xenopus oocytes | ||
| 10008439 |
D- |
- | >98% |
|
2008-01-17 | 5.657165320866 | d-myo-inositol-1-2-diphosphate-sodium-salt | 1,2-IP2 (sodium salt); Ins(1,2)P2 (sodium salt) | inositols phosphates IP3 signals transductions InsP phosphitidylinositols phospholipases C PLC signaling signalling PtdIns initiating Ca2+ calcium release phosphoinositols | ||
| 10009851 |
D- |
- | >98% |
|
2007-06-04 | 6.977237569061 | d-myo-inositol-1-3-4-5-6-pentaphosphate-ammonium-salt | 1,2,4,5,6-IP5 (sodium salt); Ins(,1,3,4,5,6)P5 | inositols phosphate IP5 signal transduction InsP phosphitidylinositol phospholipase C PLC phosphioinositide 3-kinase PI3-K Akt cancer angiogenesis PKB protein kinase B | ||
| 10007784 |
D- |
- | >98% |
|
2006-01-13 | 12.172314303253 | d-myo-inositol-1-3-4-5-6-pentaphosphate-sodium-salt | 1,3,4,5,6-IP5 (sodium salt); Ins(1,3,4,5,6)P5 (sodium salt) | phosphoinositides 3-kinases PI3-K/Akt phosphates IP3 signals transductions cells growh proliferation anticancers agents isomers InsP phosphitidylinositols phospholipases messengers cellular PKB apoptosis ovarian lung breast antiangiogenic in vitro capillary tubes HUVEC antitumor xenografts nude mice PH domains Grp1 | ||
| 60980 |
D- |
210488-61-2 | >98% |
|
40.873005130228 | d-myo-inositol-1-3-4-5-tetraphosphate-sodium-salt | Ins(1,3,4,5)-P4 (sodium salt); 1,3,4,5-IP4 (sodium salt) | IP4 inositols tetraphosphates salts phosphorylation 1,4,5-triphosphate-3-kinase intracellular calcium InsPs | |||
| 10008442 |
D- |
- | ≥95% |
|
2008-12-04 | 4.009613259668 | d-myo-inositol-1-3-4-6-tetraphosphate-ammonium-salt | 1,3,4,6-IP (ammonium salt); Ins(1,3,4,6)P4 (ammonium salt) | inositol myo-inositol inositol phosphate second messenger inositol-1,2,3,4,5,6-hexakisphosphate phytic acid signal transduction | ||
| 10007781 |
D- |
- | >98% |
|
2006-01-11 | 7.504348391289 | d-myo-inositol-1-3-5-triphosphate-sodium-salt | 1,3,5-IP3 (sodium salt); Ins(1,3,5)P3 (sodium salt) | phosphates IP3 signals transductions InsP phosphitidylinositols phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels meso compounds Xenopus oocytes | ||
| 10008443 |
D- |
208584-52-5 | >98% |
|
2006-12-21 | 26.705638812154 | d-myo-inositol-1-3-diphosphate-sodium-salt | Ins(1,3)-P2 (sodium salt); 1,3-IP2 (sodium salt) | phosphates IP2 signals transductions InsP phosphatidyls inositols messengers cellular phospholipases PLC ER endoplasmic reticulum calcium Ca2+ dephosphorylation | ||
| 10007783 |
D- |
- | >98% |
|
2006-01-13 | 5.975069718495 | d-myo-inositol-1-4-5-6-tetraphosphate-sodium-salt | 1,4,5,6-IP4 (sodium salt); Ins(1,4,5,6)P4 (sodium salt) | oligophosphates isomers IP3 signals transductions InsP phosphatidylinositols phospholipases intestinal epithelial cells strains incubation times Salmonella epidermal growth factor EGF PI3-kinases cellular calcium Ca2+ Ca++ channels D/L racemic mixture Xenopus oocytes | ||
| 60960 |
D- |
103476-24-0 | >98% |
|
27.423208669782 | d-myo-inositol-1-4-5-triphosphate-potassium-salt | Ins(1,4,5)-P3 (potassium salt); 1,4,5-IP3 (potassium salt) | IP3 inositols triphosphates salts phosphorylation receptors messengers inositol-4,5-biphosphate hydrolysis intracellular calcium PLC phospholipases InsPs | |||
| 10008205 |
D- |
- | >98% |
|
2006-01-30 | 14.203335635359 | d-myo-inositol-1-4-5-triphosphate-sodium-salt | 1,4,5-IP3 (sodium salt); Ins(1,4,5)P3 (sodium salt) | phosphates IP3 signals transductions InsP phosphitidylinositols Ins(1,4,5)P3 phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels analogs agonists rat hepatic receptors | ||
| 10008438 |
D- |
- | >98% |
|
2007-01-08 | 26.383159530386 | d-myo-inositol-1-4-diphosphate-sodium-salt | 1,4-IP2 (sodium salt); Ins(1,4)-P2 (sodium salt) | phosphates IP2 signals transductions InsP phosphatidyls inositols messengers cellular phospholipases PLC ER endoplasmic reticulum calcium Ca2+ dephosphorylation signalling | ||
| 10008422 |
D- |
120965-76-6 | ≥98% |
|
2009-08-04 | 53.600546961325 | d-myo-inositol-1-5-6-triphosphate-sodium-salt | Ins(1,5,6)-P3 (sodium salt); 1,5,6-IP3 (sodium salt) | phosphates IP2 signal transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositol IP3 second messengers trisphosphates PtdIns phosphatidylinositol D-myos PIPS | ||
| 10008441 |
D- |
- | >98% |
|
2007-06-13 | 8.479060773480 | d-myo-inositol-1-5-diphosphate-sodium-salt | 1,5-IP2 (sodium salt); Ins(1,5)-P2 (sodium salt) | inositol phosphates IP3 signaling transduction signalling cells InsP phosphitidylinositols phospholipases cPLC | ||
| 10007777 |
D- |
- | >98% |
|
2006-01-13 | 10.976823204420 | d-myo-inositol-1-phosphate-sodium-salt | Ins(1)P1 (sodium salt); 1-IP1 (sodium salt) | phosphates IP1 signals transductions InsP phosphatidylinositols phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels meso compounds Xenopus oocytes | ||
| 10008456 |
D- |
- | >98% |
|
2007-06-25 | 11.392734806629 | d-myo-inositol-2-3-4-5-tetraphosphate-ammonium-salt | 2,3,4,5-IP4 (ammonium salt); Ins(2,3,45)-P4 (ammonium salt) | inositol phosphates IP3 signals transduction InsP phosphitidylinositols phospholipases cPLC signaling signalling | ||
| 10008423 |
D- |
- | ≥98% |
|
2008-09-30 | 4.705987313279 | d-myo-inositol-2-3-5-triphosphate-ammonium-salt | Ins(2,3,5)P3 (ammonium salt); 2,3,5-IP3 (ammonium salt) | phosphates IP3 signal transduction InsP phosphitidylinositols phospholipase C PLC cell signaling calcium channels | ||
| 10007779 |
D- |
- | >98% |
|
2006-01-13 | 6.550952226194 | d-myo-inositol-2-4-5-triphosphate-sodium-salt | 2,4,5-IP3 (sodium salt); Ins(2,4,5)P3 (sodium salt) | phosphates IP3 signals transductions InsP phosphitidylinositols Ins(1,4,5)P3 phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels analogs agonists rat hepatic receptors | ||
| 10008419 |
D- |
- | ≥98% |
|
✓ | 2009-08-04 | 50.000336514314 | d-myo-inositol-2-4-diphosphate-sodium-salt | Ins(2,4)-P2 (sodium salt); 2,4-IP2 (sodium salt) | phosphates IP2 signals transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositols IP3 second messengers biphosphates bisphosphates PtsIns phosphatidylinositol 106358-02-5 | |
| 10008424 |
D- |
- | ≥98% |
|
2008-10-10 | 4.705987313279 | d-myo-inositol-2-5-6-triphosphate | Ins(2,5,6)P3 (sodium salt); 2,5,6-IP3 (sodium salt) | phosphates IP3 signal transduction InsP phosphitidylinositols phospholipase C PLC cell signaling calcium channels L-myo-Inositol-2,4,5-triphosphate (sodium salt) | ||
| 10007782 |
D- |
- | >98% |
|
2006-01-13 | 5.798905551170 | d-myo-inositol-3-4-5-6-tetraphosphate-sodium-salt | 3,4,5,6-IP4 (sodium salt); Ins(3,4,5,6) - P4 (sodium salt) | oligophosphates isomers kinases IP3 signals transductions InsP phosphitidylinositols phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels Xenopus oocytes | ||
| 10008425 |
D- |
- | >98% |
|
2007-06-05 | 1.983812154696 | d-myo-inositol-3-4-5-triphosphate-sodium-salt | 3,4,5-IP4 (sodium salt); Ins(3,4,5)-P3 (sodium salt) | inositols phosphate IP3 signal transduction InsP phosphitidylinositol phospholipase C PLC | ||
| 10007778 |
D- |
- | >98% |
|
2006-01-13 | 10.883176795579 | d-myo-inositol-3-phosphate-sodium-salt | Ins(3)P1 (sodium salt); 3-IP1 (sodium salt) | phosphates IP3 signals transductions InsP phosphitidylinositols phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels dephosphorylation | ||
| 10008418 |
D- |
- | >98% |
|
2007-01-04 | 8.066533149170 | d-myo-inositol-4-5-diphosphate-sodium-salt | Ins(4,5)-P2 (sodium salt); 4,5-IP2 (sodium salt) | IP3 myo-inositols Ins(1,4,5)P3 Ins(4,5)P2 cells signaling transduction diphosphates salts InsPs phosphorylation receptors messengers inositol-4,5-biphosphate hydrolysis intracellular calcium PLC phospholipases signalling | ||
| 10008437 |
D- |
142760-33-6 | >98% |
|
2006-10-18 | 22.115035516968 | d-myo-inositol-4-phosphate-ammonium-salt | 4-IP1 (ammonium salt); Ins(4)P1 (ammonium salt) | phosphates IP4 signals transductions InsP phosphatidylinositols phospholipases C PLC messengers cellular cells hydrolysis ER endoplasmic reticulum calcium Ca2+ Ca++ channels dephosphorylation polyphosphates monophosphatase PtdIns | ||
| 9000639 | Docosahexaenoyl Serotonin Exclusive New | 283601-58-1 | ≥98% |
|
✓ | 2010-05-18 | 0E-12 | docosahexaenoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA | ||
| 10010238 | Erbstatin Analog | 63177-57-1 | ≥98% |
|
2008-06-06 | 0.198895027624 | erbstatin-analog | Methyl 2,5-dihydoxycinnamate | analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers | ||
| 10483 | Erlotinib New | 183321-74-6 | ≥98% |
|
2010-08-11 | 0E-12 | erlotinib | Tarceva™; CP 358,774; NSC 718781 | tyrosine kinase inhibitor inhibits inhibiting epidermal growth factor receptors EGFR cancers tumor cyclin-dependent cyclin dependent kinase 2 CDK-2 CDK 2 CDK2 JAK-2 JAK2 JAK JAK2V617F CP-358,774 CP-358774 CP 358774 CP358774 CP358,774 NSC-718781 NSC718781 OSI-744 OSI744 R-1415 R1415 R 1415 OSI 744 | ||
| 10010501 | Farnesyl Thiosalicylic Acid | 162520-00-5 | ≥96% |
|
2008-06-02 | 21.547403314917 | farnesyl-thiosalicylic-acid | Salirasib; FTS | ras inhibitors inhibition inhibits cancer anti-cancer anticancer prenylation farnesylation signal transduction oncogene atherosclerosis farnesylthiosalicylic acid | ||
| 13175 | Farnesyl Thiosalicylic Acid Amide Exclusive | 1092521-74-8 | ≥96% |
|
✓ | 2009-02-26 | 10.863149171270 | farnesyl-thiosalicylic-acid-amide | Salirasib Amide; FTS Amide | Ras degradation cells signaling signalling tumors glioblastoma cancers inhibitors inhibits inhibition | |
| 13179 | FKGK 11 Exclusive | 1071000-98-0 | ≥98% |
|
✓ | 2009-06-30 | 32.809823204419 | fkgk-11 | Phospholipases A2 iPLA2 inhibitors signal transduction inhibition PLAs | ||
| 13166 | Gefitinib | 184475-35-2 | ≥98% |
|
2010-02-11 | 60.844250764133 | gefitinib | Iressa™; ZD1839 | EGFR-TK EGFRs TKs epidermal growth factors inhibitors cancers signal transduction tyrosine kinases inhibits inhibited NSCLC | ||
| 13355 | Geldanamycin New | 30562-34-6 | 98% |
|
2010-07-29 | 3.207182320442 | geldanamycin | NSC 122750 | NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors | ||
| 13332 |
Glycyl- |
913844-45-8 | ≥98% |
|
2010-01-27 | 81.578635739133 | glycyl-h-1152-hydrochloride | Rho Kinase Inhibitor IV | Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV | ||
| 13127 | GW 4869 | 6823-69-4 | ≥90% |
|
2009-06-10 | 56.436985880908 | gw-4869 | inhibitors sphingomyelin sphingomyelinase neutral acidic TNF-α ceramides cells death GW4869 gw-4869 | |||
| 13345 | GYY 4137 Exclusive | 106740-09-4 | ≥95% |
|
✓ | 2009-07-31 | 16.215911602209 | gyy-4137 | hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3 | ||
| 10007653 |
H- |
- | ≥95% |
|
2010-02-25 | 112.642857142857 | h-1152-hydrochloride | Rho kinase ROCK cytoskeletal cytoskeleton smooth muscles contractions vasoconstriction neurons neurite inhibitors Y-27632 HA-1077 PKA PKC MLCK H1152 H 1152 inhibition inhibits 451462-58-1 | |||
| 10010556 |
H- |
127243-85-0 | ≥98% |
|
2008-07-08 | 14.637790055249 | h-89 | 5-Isoquinolinesulfonamide; Protein Kinase Inhibitor H-89 | inhibitors inhibits inhibition PKA cAMP cell signaling protein kinase S6K1 MSK1 ROCK-II ROCKII PKB.alpha. PKBalpha PKBa MAPKAP-K1b MAPKAPK1b H89 H 89 | ||
| 10010249 |
H- |
113276-94-1 | ≥98% |
|
2008-07-17 | 10.317513812155 | h-8-hydrochloride | Protein Kinase Inhibitor H-8 | PKA PKG PKC MLCK cyclin C CDK8 cyclin H CDK7 p36 signal transduction inhibitor inhibits inhibition transcription 84478-11-5 | ||
| 13312 |
H- |
- | ≥98% |
|
2009-07-14 | 7.318895027624 | h-9-hydrochloride | Protein Kinase Inhibitor H-9 | proteins kinases inhibitors inhibits inhibitions PKCs PKAs PKGs cGMPs cAMPs signal transductions competitive potent PKA-mediated mediated phosphorylation 84468-17-7 | ||
| 13205 | Halopemide Exclusive | 59831-65-1 | ≥98% |
|
✓ | 2009-04-21 | 18.747734806630 | halopemide | R34301; NSC 354856 | inhibitors phospholipases D PLD PLD1 PLD2 dopamine receptors inhibits inhibition potent cells DP nueraleptic | |
| 10010329 | HDBA | 125697-93-0 | ≥98% |
|
2008-07-08 | 0E-12 | hdba | Lavendustin C; NSC 666251 | EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition | ||
| 10202 | Hsp90α (human recombinant) New | - | ≥80% | 2010-03-16 | 93.359453652547 | hsp90-human-recombinant | Hsp84; Heat Shock Protein 90α | heat shock proteins molecular chaperones Hsp90.alpha. Hsp90AA1 HspCAL4 HspN 90kDa cytosolic class A member 2 heat-shock 1 Hsp90AA2 Hsp86 Hsp90a | |||
| 10342 | Hsp90β (human recombinant) New | - | ≥85% | 2010-03-16 | 99.888095238095 | hsp90-human-recombinant | Hsc90; Hsp90 AB1; Heat Shock Protein 90β | heat shock proteins molecular chaperones Hsp90.beta. 90kDa alpha cytosolic class B member 1 Hsp90beta Hsp90AB1 Hsp90b | |||
| 13347 | IBMX | 28822-58-4 | ≥98% |
|
2009-10-27 | 428.225124807127 | ibmx | NSC 165960; 1-Methyl-3-Isobutylxanthine; Isobutylmethylxanthine | inhibitor cAMP cGMP phophodiesterases PDE1 PDE2 PDE3 PDE4 PDE5 PDE7 PDE11 PDE8A PDE8B PDE9 cyclic-nucleotides methylxanthines caffeine theophylline adenosine receptors antagonist SC 2964 SC-2964 SC2964 IMX NSC165960 NSC-165960 xanthine | ||
| 13624 | Icariin | 489-32-7 | ≥97% |
|
2010-02-11 | 62.642659719415 | icariin | PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction | |||
| 13314 |
Indirubin- |
160807-49-8 | ≥98% |
|
2009-07-15 | 21.878453038674 | indirubin-3-monoxime | glycogen synthase kinase-3β GSK-3β tau proteins Alzheimer's diseases cyclin-dependent kinases CDK CDK1 cyclin A B E D1 CDK4 CDK2 CDK5 p35 growth proliferation synchronization cells arrest G2/M phases phosphorylation inhibits inhibition inhibitors | |||
| 13659 |
IWR- |
1127442-82-3 | ≥98% |
|
✓ | 2010-03-23 | 200.000000000000 | iwr-1-endo | Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expression transcription inhibitors inhibits inhibition proteasomes Apc Axin2 Ck1 Gsk3β IWR-1-exo | ||
| 13598 |
IWR- |
1127442-87-8 | ≥98% |
|
✓ | 2010-03-23 | 200.000000000000 | iwr-1-exo | Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expression transcription inhibitors inhibits inhibition controls | ||
| 10011246 |
Janex- |
202475-60-3 | ≥98% |
|
2008-12-17 | 6.428950276243 | janex-1 | WHI-P131 | inhibitors inhibits inhibition JAK3 apoptosis leukemias anti-inflammatory antiinflammatory lymphocytes WHIP131 Janex 1 | ||
| 10008131 |
JNJ- |
627512-69-0 | >98% |
|
2006-10-18 | 14.805897790055 | jnj-10198409 | PDGF-BB tyrosine kinases inhibits inhibition inhibitors growth factors receptors platelet-derived antiangiogenic antiproliferative coronary artery smooth muscle cells antagonists ATP binding hydrolysis tumors angiogenesis | |||
| 10009458 |
JTE- |
383150-41-2 | >98% |
|
2007-01-18 | 87.972562154695 | jte-013 | reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers | |||
| 10010239 | Kenpaullone | 142273-20-9 | >98% |
|
2007-09-04 | 18.745782688766 | kenpaullone | NSC 664704; 9-Bromopaullone | GSK-3.beta. cyclin-dependent kinase cyclin CDK inhibitors inhibits inhibition proliferations cell cycle cancers | ||
| 13243 | KH7 | 330676-02-3 | ≥98% |
|
2009-09-18 | 119.238545119705 | kh7 | sAC soluble adenylyl cyclase cAMP inhibitors inhibits inhibition cells signaling signal transduction second messenger KH 7 KH-7 signalling cyclic AMP | |||
| 13318 |
KN- |
127191-97-3 | ≥98% |
|
2009-07-16 | 12.068784530386 | kn-62 | inhibitors calcium calmodulin-dependent kinase II CaM kinase II purinergic receptors P2RX7 P2X7 inhibition inhibited selective permeableCaMKII calcium ca modulation CaMK11CaMK2 | |||
| 13319 |
KN- |
139298-40-1 | ≥98% |
|
2009-08-05 | 22.200000000000 | kn-93 | inhibitors inhibits inhibition Ca2+ calmodulin dependent Ca2+/calmodulin-dependent kinase II CaMKII histamine parietal cells cardiac myocytes 5-LO 5-lipoxygenase HIF-1a HIF-1α HIF1α colon cancers phosphorylation CAM | |||
| 10011011 | KT 5720 | 108068-98-0 | ≥98% |
|
2009-01-20 | 119.441215469613 | kt-5720 | PKAs cAMPs signaling proteins kinase inhibitors inhibits inhibition phosphorylase kinase PDK1 MEK MSK1 PKα GSK3β KT5720 KT-5720 | |||
| 10010965 | KT 5823 | 126643-37-6 | ≥95% |
|
2009-01-15 | 128.739530386740 | kt-5823 | cGMP PKGs proteins kinases G inhibitors inhibits inhibition nitric oxides NO antibiotic KT5823 KT-5823 | |||
| 10010631 | Latrunculin B | 76343-94-7 | ≥97% |
|
2009-02-20 | 9.640552486188 | latrunculin-b | monomeric actins G-actin G actins F-actin F inhibitors inhibits inhibition cytoskeleton | |||
| 10008426 |
L- |
2068-89-5 | ≥98% |
|
2009-09-14 | 4.434301499604 | l-myo-inositol-1-4-5-triphosphate-sodium-salt | 1,4,5-IP3 (sodium salt); Ins(1,4,5)P3 (sodium salt); D-myo-Inositol-3,5,6-triphosphate (sodium salt) | inositols phosphates calcium cells signaling isomers D-myo-inositol-1,4,5-triphosphate 2068-89-5 | ||
| 10010497 | Manumycin A | 52665-74-4 | ≥98% |
|
2008-06-25 | 13.340000000000 | manumycin-a | UCF 1C; NSC 622141 | farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB | ||
| 10009518 |
MEK 1 (Phospho- |
- | 2007-01-12 | 0E-12 | mek-1-phospho-thr292-polyclonal-antibody | antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting | |||||
| 10009517 |
MEK 1 (Phospho- |
- | 2007-01-11 | 0E-12 | mek-1-phospho-thr386-polyclonal-antibody | antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting | |||||
| 10010236 |
ML- |
105637-50-1 | ≥98% |
|
2008-01-21 | 1.434254143646 | ml-9 | PKB Akt inhibitors inhibits inhibition serine/threonine kinase PKA P90S6 MAP kinases cancers anti-cancers insulin glucose transports calcium channels calmodulin intracellular smooth muscles asthma | |||
| 10230 |
(+)- |
24570-49-8 | ≥95% |
|
2010-05-06 | 0E-12 | -muscarine-iodide-salt | neurochemistry 300-54-9 2438-77-9 poisonous mushroom acetylcholine G proteins Alzheimer's disease signal transduction L-muscarine Amanita muscaria | |||
| 13746 | MyD88 Polyclonal Antibody | - |
|
2010-02-05 | 97.777777777778 | myd88-polyclonal-antibody | proteins antibodies western blots blotting immunoblotting WB interleukin-1 interleukins 1 IL-1 ILs signaling N-terminal NF-κB NFκB NF κB death domain signalling | ||||
| 13136 |
N- |
7512-17-6 | ≥98% |
|
2009-03-13 | 0.234696132597 | n-acetyl-d-glucosamine | Marine Sweet; GlcNAc; NSC 524344; NAG | monosaccharide glucose O-GlcNAc alzheimer's disease genes expressions chitin cells signalling signaling post-translational modification signal transduction | ||
| 10011060 |
N- |
7772-94-3 | ≥95% |
|
2008-11-11 | 2.088397790055 | n-acetyl-d-mannosamine | ManNAc | acids sialylation proteinuria glomerular diseases neuromuscular disorders HIBM sialic | ||
| 10011203 |
N- |
137173-46-7 | ≥98% |
|
2009-01-06 | 16.011943746860 | n-dodecanoyl-l-homoserine-lactone | C12-HSL; dDHL | quorum sensing bacteria biofilm gene expressions NF-kb NFkb macrophage keratinocyte C12-Homoserine Lactone | ||
| 13755 |
NF- |
- |
|
2010-02-05 | 73.552164518109 | nf-b-p50-monoclonal-antibody-clone-2j10d7 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry | ||||
| 13754 |
NF- |
- |
|
2010-04-27 | 34.441053406998 | nf-b-p50-polyclonal-antibody | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies | ||||
| 13756 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-monoclonal-antibody-biotin-clone-112a1021 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones | ||||
| 13752 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-monoclonal-antibody-clone-112a1021 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC | ||||
| 13751 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-nls-polyclonal-antibody | Nuclear Factor-κB (p65) Nuclear Localization Signal | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies | |||
| 13757 |
NF- |
- |
|
2010-02-11 | 108.489855460684 | nf-b-p65-polyclonal-antibody-aa-2-17 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 | ||||
| 13753 |
NF- |
- |
|
2010-02-11 | 111.440352698253 | nf-b-p65-polyclonal-antibody-aa-538-546 | NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 | ||||
| 10010422 | Nilotinib | 641571-10-0 | ≥98% |
|
2009-10-23 | 16.523608607154 | nilotinib | AMN107 | tyrosine kinases inhibitors therapy cancer Bcr/Abl chronic myeloid leukemia MLL philadelphia chromosomes acute lymphoblastic ALL imatinib gleevec genes expression DNA helicase complex cyclins cyclin-dependent cells proliferation | ||
| 10011255 | NSC 210902 | 51726-83-1 | ≥95% |
|
2008-09-15 | 1.672375690607 | nsc-210902 | Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 | |||
| 13196 | NSC 23766 (hydrochloride) New | 1177865-17-6 | ≥98% |
|
2010-07-20 | 0E-12 | nsc-23766-hydrochloride | 733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration angiogenesis leukemia cancers gene expression Rac1 Inhibitor | |||
| 10011200 |
N- |
202284-87-5 | >98% |
|
2009-01-06 | 11.588664825045 | n-tetradecanoyl-l-homoserine-lactone | tDHL; C14-HSL | quorum sensing bacterias biofilm gene expressions growth proteolytic acitivity activities migration | ||
| 10009277 | Nuclear Extraction Kit | - | 2007-05-11 | 106.650911602210 | nuclear-extraction-kit | assays kits proteins transcription factors cytoplasmic fractions cells tissue homogenates EMSA extracts electrophoretic mobility shift western blotting blots | |||||
| 13641 |
NVP- |
- | 98% |
|
2010-07-28 | 34.935248618785 | nvp-aew541-hydrochloride | 475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 | |||
| 10006803 |
O- |
317321-41-8 | >98% |
|
2005-09-12 | 17.105911602209 | o-1602 | abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant | |||
| 10006804 |
O- |
35482-50-9 | >97% |
|
2005-09-12 | 0.884493554327 | o-1821 | abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation | |||
| 10004914 |
O- |
536697-79-7 | >98% |
|
2005-09-09 | 3.982550644567 | o-1918 | antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 | |||
| 10010299 |
Oleoyl 3- |
- | ≥95% |
|
✓ | 2009-10-14 | 13.700418310970 | oleoyl-3-carbacyclic-phosphatidic-acid | 3-ccPA 18:1 | cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA oleate transcellular migration MM1 cells mesothelial autotoxin cancer survival growth migration invasion metastasis antagonist LPA1 LPA2 LPA3 476310-24-4 | |
| 9000629 | Oleoyl Serotonin Exclusive New | 1002100-44-8 | ≥98% |
|
✓ | 2010-05-18 | 0E-12 | oleoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA | ||
| 10011301 | p38 MAPK Monoclonal Antibody (Clone 9F12) | - |
|
2008-05-22 | 2.615138121547 | p38-mapk-monoclonal-antibody-clone-9f12 | p38 Mitogen-activated Protein Kinase; p38 MAPKα | serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC | |||
| 600008 |
p53 Cell- |
- |
|
2009-03-10 | 2.083885819521 | p53-cell-based-activation-translocation-assay-kit | p53 dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts assays cell-based assay cell based assay cba | ||||
| 10007358 | Palmitic Acid methyl ester | 112-39-0 | >99% |
|
2006-02-17 | 1.746484178804 | palmitic-acid-methyl-ester | MP; Methyl Palmitate | esters saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 16-carbon dietary fats plasma lipoproteins expression COX-2 cyclooxygenase-2 cyclooxygenases proteins acylation lipids anchoring signaling signalling molecules | ||
| 10010298 |
Palmitoleoyl 3- |
910228-13-6 | ≥95% |
|
✓ | 2009-11-03 | 8.451954509578 | palmitoleoyl-3-carbacyclic-phosphatidic-acid | 3-carbacyclic PA; 3-ccPA 16:1 | cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitoleate transcellular migration MM1 cells mesothelial autotoxins cancer survival growth migration invasion metastasis NPP2 ENPP2 ectonucleotide pyro phosphatase/phosphodiesterase 2 | |
| 10010293 |
Palmitoyl 3- |
476310-22-2 | ≥95% |
|
✓ | 2009-10-07 | 13.564666315881 | palmitoyl-3-carbacyclic-phosphatidic-acid | 3-ccPA 16:0; 3-carbacyclic PA | cyclic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitate transcellular migration MM1 cells mesothelial autotoxins cancers survival growth migration invasion metastasis | |
| 9000630 | Palmitoyl Serotonin Exclusive New | 212707-51-2 | ≥98% |
|
✓ | 2010-05-18 | 0E-12 | palmitoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA | ||
| 13034 | PD 0325901 | 391210-10-9 | ≥98% |
|
2009-03-13 | 55.542829687333 | pd-0325901 | MEK ERK RAS RAF MAPK tumors stem cells cancers differentiation signaling GSK3 kinase inhibitors inhibits inhibition pd325901 pd 325901 PD0325901 | |||
| 10006727 | PD 169316 | 152121-53-4 | >98% |
|
2006-04-12 | 19.282067876874 | pd-169316 | p38 mitogen-activated proteins kinases MAPK enzymes signal transductions inhibitors inhibits A C.alpha. apoptosis neuronal cells trophic factors potassium nerves growth pd169316 pd-169316 | |||
| 13032 | PD 173074 | 219580-11-7 | ≥98% |
|
2009-07-29 | 25.174872928177 | pd-173074 | fibroblast growths factors receptors FGFRs FGFR1 tyrosine kinase activity activities activation signals propagation inhibitors inhibition inhibits autophosphorylation PDGFR c-Src cSrc c Src EGFR InsR MEK PKC FGFR2 FGFR3 FGFR4 FGFR5 angiogenesis cancers tumors self-renewal self renewal stems cells ERK1/2 ERK-1/2 ERK 1/2 | |||
| 10012431 | PD 184161 Exclusive | 212631-67-9 | ≥98% |
|
✓ | 2009-06-09 | 18.628839779005 | pd-184161 | MEK inhibitors MAP kinase ERK signaling cancer MEK 1/2 inhibition inhibited ERK 1/2 potent selective pd184161 | ||
| 10006726 | PD 98059 | 167869-21-8 | >98% |
|
2005-09-12 | 33.561878453039 | pd-98059 | potent selective MAPK mitogen-activated proteins kinases family serines threonines cellular PD-98059 programs cells proliferation differentiation movement death noncompetitive inhibits inhibitors inhibition pathways activation MAPKK1 Raf MEK MAPKK2 MAPKK-1 PD98059 MAPKK-2 ERK | |||
| 10007192 |
PH Domain Leucine- |
- | 2006-01-30 | 2.505925414364 | ph-domain-leucine-rich-repeat-protein-phosphatase-blocking-peptide | KIAA0606 Protein; PHLPP; PLEKHE1 Protein; SCOP; Suprachiasmatic Nucleus Circadian Oscillatory Protein | western blotting blots signaling signalling WB IHC ICC immunohistochemistry formalin-fixed paraffin-embedded immunocytochemistry proteins kinases Akt cells growth death serine residues Ser473 C-terminal hydrophobic motifs human cancers dephosphorylates dephosphorylation reduces activity apoptosis apoptotic colon glioblastomas lines tumors brain | ||||
| 10007191 |
PH Domain Leucine- |
- |
|
2006-01-04 | 3.757658839778 | ph-domain-leucine-rich-repeat-protein-phosphatase-polyclonal-antibody | Suprachiasmatic Nucleus Circadian Oscillatory Protein; SCOP; PLEKHE1 Protein; PHLPP; KIAA0606 Protein | proteins diseases antibodies antisera antiserum western blots blotting immunocytochemistry ICC immunohistochemistry IHC cancers WB immunoblotting | |||
| 700240 | Phosphatidic Acid Assay Kit | - |
|
2009-08-24 | 60.175303867403 | phosphatidic-acid-assay-kit | PA Assay Kit | assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin | |||
| 13581 |
Phosphine- |
- | ≥95% |
|
✓ | 2009-12-03 | 44.804609177523 | phosphine-biotin | DAz-1 DAz1 DAz 1 DAz-2 DAz2 DAz 2 sulfenic acids click chemistry azido groups ROS oxidation cysteine posttranslational modifications staudinger ligation P-Biotin click-tag | ||
| 10009209 |
PI- |
371935-74-9 | >98% |
|
2007-01-19 | 81.993030781373 | pi-103 | phosphoinositides PI3-kinases Phosphatidylinositols cancers Glioma DNA-PK mTOR inhibitors inhibits inhibition anti-proliferatives proliferation PI103 | |||
| 13326 |
Pifithrin- |
63208-82-2 | ≥95% |
|
2009-07-16 | 22.042012628255 | pifithrin | p53 apoptosis DNA damage cyclin D1 C8 cells HUVECs endothelial cells dependent independent inactivator | |||
| 10009210 |
PIK- |
372196-67-3 | ≥98% |
|
2010-03-10 | 93.284757903622 | pik-75 | p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g | |||
| 10459 | PKC 412 New | 120685-11-2 | ≥98% |
|
2010-07-27 | 0E-12 | pkc-412 | CGP 41251; N-Benzoylstaurosporine; Midostaurin; CGP 41231 | inhibitors inhibits inhibition PKC412 PKC-412 serine/threonine serine threonine tyrosines kinases PKCα PKCβ PKCγ PKC-α PKC-β PKC-γ Syk Flk-1 Flk1 Akt PKA c-Kit cKit C-Fgr cFgr FLT3 FLT-3 PDFRβ PDFR-β VEGFR1 VEGF2 nitric oxide synthase eNOS apoptosis cancers angiogenesis signal transduction | ||
| 10007839 |
PLC thio- |
- | >98% |
|
2006-01-18 | 23.088356865152 | plc-thio-pip2-sodium-salt | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono | |||
| 10272 | Prostratin | 60857-08-1 | ≥98% |
|
2009-06-11 | 0.773480662983 | prostratin | SA 101A; NSC 623310; 13-O-Acetylphorbol | HIV-1 AIDS NF-κB PKC T cells CD4 CXCR4 CCR5 stillingia factor S7 SFS7 13-O-acetyl-12-deoxy phorbol | ||
| 10011210 | Protein Phosphatase 2A C subunit (human recombinant) Exclusive | - | ≥90% | ✓ | 2008-07-17 | 322.995745856353 | protein-phosphatase-2a-c-subunit-human-recombinant | PP2A Cα | PP2AC.alpha. PP2ACalpha PP2ACa proteins phosphorylation serine threonine phosphatase cell growth cycle differentiation tumor suppressor | ||
| 10011237 | Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) Exclusive | - | ✓ | 2008-07-17 | 7.620110497237 | protein-phosphatase-2a-c-subunit-human-recombinant-l309-deletion | PP2A Cα; PP2A Δ309; PP2A L309 | proteins phosphatases serine threonine cellular tumors enzyme kinetics regulations substrates phosphorylasion PP2As octahistidine-tag streptactin-tag | |||
| 10009506 | PSD95 Polyclonal Antibody | - | 2007-01-03 | 1.799830004250 | psd95-polyclonal-antibody | Postsynaptic Density Protein of 95 | antibodies WB western blot PDZ domain glutamate receptors signaling proteins synapse NMDAR phosphorylation proteins signalling blotting immunoblotting | ||||
| 10008099 |
PtdIns- |
- | >98% |
|
2006-01-17 | 24.657628559285 | ptdins-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol C-8 (sodium salt); DOPI (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | ||
| 10007710 |
PtdIns- |
- | >98% |
|
2005-12-30 | 29.373898096991 | ptdins-1-2-dipalmitoyl-ammonium-salt | DPPI (ammonium salt); Phosphatidylinositol C-16 (ammonium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | ||
| 9000305 |
PtdIns- |
- | ≥95% |
|
✓ | 2009-04-20 | 30.446568769991 | ptdins-1-arachidonoyl-2-arachidonoyl-d8-ammonium-salt | arachidonic acids deuterium atoms AA GC/MS LC/MS mass spectrometry deuterateds | ||
| 10008390 |
PtdIns- |
- | >98% |
|
2009-02-03 | 1.107182320442 | ptdins-3-4-5-p3-1-2-dihexanoyl-ammonium-salt | Phosphatidylinositol-3,4,5-triphosphate C-16 (sodium salt); DHPI-3,4,5-P3 (ammonium salt); PIP3C-16 (sodium salt) | phosphatidylinositols cell signalling pleckstrin homology protein binding PIP3 PtdIns phospholipid signal transduction C6 C-6 | ||
| 10007764 |
PtdIns- |
- | >98% |
|
2005-12-30 | 35.852083407592 | ptdins-3-4-5-p3-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol-3,4,5-trisphosphate (sodium salt); DOPI-3,4,5-P3 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP3 mono PIPs | ||
| 9000414 |
PtdIns- |
- | ≥98% |
|
✓ | 2009-09-25 | 24.111383340416 | ptdins-3-4-5-p3-1-2-dipalmitoyl-d62-sodium-salt | Phosphatidylinositol-3,4,5-trisphosphate C-16-d62 (sodium salt); DPPI-3,4,5-P3-d62 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids PIPs phosphatidylinositols triphosphates phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP3 mono di | |
| 10009531 |
PtdIns- |
- | >98% |
|
✓ | 2007-01-16 | 18.011325966850 | ptdins-3-4-5-p3-biotin-sodium-salt | Phosphatidylinositol-3,4,5-triphosphate C-8-biotin (sodium salt); PIP3-biotin | phosphatidylinositols triphosphates phospholipids phophorylation intracellular signals transduction PIP2 biotinimides dioctanoyl PTEN PI3k affinity probes ligands detection transmembranes receptors nucleic acids proteins binding kinases biotins biotinylated | |
| 10010383 |
PtdIns- |
- | ≥95% |
|
✓ | 2008-08-13 | 7.706857734806 | ptdins-3-4-5-p3-fluorescein-ammonium-salt | PIPs PIP3-fluorescein fluorescent PI3K PTENs phosphatidylinositol phosphates phosphorylated kinases binding proteins PIPs | ||
| 10007759 |
PtdIns- |
- | >98% |
|
2005-12-30 | 22.008742617641 | ptdins-3-4-p2-1-2-dihexanoyl-sodium-salt | Phosphatidylinositol-3,4-bisphosphate C-6 (sodium salt); DHPI-3,4-P2 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono PIPs | ||
| 10008400 |
PtdIns- |
- | >98% |
|
2006-11-16 | 24.036998816101 | ptdins-3-4-p2-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol-3,4-bisphosphate C-8 (sodium salt); DOPI-3,4-P2 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono PIPs | ||
| 10008396 |
PtdIns- |
- | >98% |
|
2008-01-21 | 23.660814405565 | ptdins-3-5-p2-1-2-dihexanoyl-sodium-salt | Phosphatidyl-3,5-bisphosphate C-6 (sodium salt); DHPI-3,5-P2 (sodium salt) | phosphatidyl inositols IP3 diacylglycerol DAG PIP1 PIP2 PIP3 signal transductions phospholipases C phospholipases D PLC PLD PIPs | ||
| 10007763 |
PtdIns- |
- | >98% |
|
2005-12-30 | 29.246704814522 | ptdins-3-5-p2-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol-3,5-bisphosphate C-8 (sodium salt); DOPI-3,5-P2 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono PIPs | ||
| 10008398 |
PtdIns- |
- | ≥98% |
|
2007-11-28 | 28.607111830825 | ptdins-3-5-p2-1-2-dipalmitoyl-sodium-salt | Phosphatidylinositol-3,5-diphosphate C-16 (sodium salt) | phosphatidylinositols diphosphates phospholipids phophorylation signal transduction IP3 diacylglycerol DAG PIP1 PIP2 PIP3 PLC PLD | ||
| 10008394 |
PtdIns- |
- | >98% |
|
✓ | 2007-06-11 | 23.870697769592 | ptdins-3-p1-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol-3-monophosphate C-8 (sodium salt); DOPI-3-P1 (sodium salt) | phosphatidyl inositols IP3 diacylglcerol DAG PIP1 PIP2 PIP3 transuction C phospholipase D PLC PLD signaling signalling | |
| 10005616 |
PtdIns- |
- | ≥99% deuterated product |
|
2005-12-30 | 22.710712312549 | ptdins-3-p1-1-2-dipalmitoyl-d62-ammonium-salt | DPPI-3-P-d62 (ammonium salt); Phosphatidylinositol-3-phosphate C16-d62 (ammonium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP1 triphosphates mono | ||
| 10007762 |
PtdIns- |
- | >98% |
|
2005-12-30 | 27.860836349780 | ptdins-4-5-p2-1-2-dihexanoyl-sodium-salt | Phosphatidylinositol-4,5-bisphosphate C-6 (sodium salt); DHPI-4,5-P2 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono PIPs | ||
| 10008115 |
PtdIns- |
- | >98% |
|
2006-01-17 | 41.216740331491 | ptdins-4-5-p2-1-2-dipalmitoyl-sodium-salt | Phosphatidylinositol-4,5-diphosphate C-16 (sodium salt); DPPI-4,5-P2 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono | ||
| 10005615 |
PtdIns- |
- | ≥99% deuterated product |
|
2006-01-30 | 25.075838674033 | ptdins-4-5-p2-1-2-dipamitoyl-d62-sodium-salt | Phosphatidylinositol-4,5-diphosphate C16-d62 (sodium salt); DPPI-4,5-P2-d62 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP2 triphosphates mono di | ||
| 10008159 |
PtdIns- |
- | >98% |
|
2006-12-21 | 57.373357888275 | ptdins-4-5-p2-biotin-sodium-salt | Phosphatidylinositol-4,5-diphosphate C-8-biotin (sodium salt) | phosphatidylinositols diphosphates phospholipids phophorylation intracellular signals transduction PIP2 biotinimides dioctanoyl PTEN PI3k affinity probes ligands detection transmembranes receptors nucleic acids proteins binding kinases PIPs biotins biotinylated | ||
| 10010388 |
PtdIns- |
- | ≥95% |
|
✓ | 2008-08-14 | 62.075276243093 | ptdins-4-5-p2-fluorescein-ammonium-salt | PIPs PIP2 fluoresceins fluorescent PI3K PTEN probes | ||
| 10007757 |
PtdIns- |
- | >98% |
|
2005-12-30 | 24.343285319652 | ptdins-4-p1-1-2-dihexanoyl-sodium-salt | DHPI-4-P1 (sodium salt); Phosphatidylinositol-4-phosphate C-6 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | ||
| 10007711 |
PtdIns- |
- | >97% |
|
2005-12-30 | 25.332503946329 | ptdins-4-p1-1-2-dioctanoyl-ammonium-salt | DOPI-4-P (ammonium salt); Phosphatidylinositol-4-phosphate C-8 (ammonium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | ||
| 10008050 |
PtdIns- |
- | >98% |
|
2005-12-30 | 22.873468823993 | ptdins-5-p1-1-2-dihexanoyl-sodium-salt | Phosphatidylinositol-5-phosphate (sodium salt); DHPI-5-P1 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | ||
| 10007758 |
PtdIns- |
- | >98% |
|
2005-12-30 | 22.710712312549 | ptdins-5-p1-1-2-dioctanoyl-ammonium-salt | DOPI-5-P1 (ammonium salt); Phosphatidylinositol-5-phosphate C-8 (ammonium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | ||
| 10010181 |
Ptd(S)Ins- |
- | >95% |
|
2008-01-07 | 28.508614692040 | ptd-s-ins-3-4-p2-1-2-dioctanoyl-sodium-salt | DOsPI-3,4-P2 | phospholipases C PIP2 PtdIns inositols phosphate PLC phosphothiotidyls Ellmans reagent analogs PIPs | ||
| 10009746 | PTEN (human recombinant) | - | ≥95% | 2008-09-04 | 2.588881215469 | pten-human-recombinant | TEP1; Phosphatidylinositol 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10 | proteins PTENs phosphatase homology tensin chromosomes enzymes lipids Sf21 cells recombinant N-terminal tumor suppressor cancers phosphoinositide hexahistidine His-tag His-tagged | |||
| 10005059 | PTEN Polyclonal Antibody | - |
|
2005-05-04 | 12.888614534636 | pten-polyclonal-antibody | TEP1; Phosphoinositide 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10 | proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions cancers endocrinology immunoblotting | |||
| 13294 | Pyrrophenone Exclusive New | 341973-06-6 | ≥90% |
|
✓ | 2010-04-07 | 51.367941988950 | pyrrophenone | phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory | ||
| 10009504 |
Raf- |
- | 2006-12-21 | 1.784898710865 | raf-1-phospho-ser301-polyclonal-antibody | phospho-specific antibodies proteins WB western blots blotting signal transduction Ras protein kinase MEK ERK phosphorylation Raf serine threonine cellular proliferation phospho-specific immunoblotting | |||||
| 10009505 |
Raf- |
- | 2006-12-22 | 5.354696132597 | raf-1-phospho-ser642-polyclonal-antibody | phospho-specific antibodies proteins WB western blot blotting signal transduction Ras protein kinase MEK ERK phosphorylation Raf serine threonine cellular proliferation immunoblotting | |||||
| 13346 | Rapamycin | 53123-88-9 | ≥98% |
|
2009-10-21 | 38.575802540001 | rapamycin | Sirolimus | immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases | ||
| 10009411 | Ribosomal S6 Kinase 2 Polyclonal Antibody | - | 2006-11-28 | 1.222375690607 | ribosomal-s6-kinase-2-polyclonal-antibody | RSK2 | wb western blotting blots antibodies p90 kinases RSK1 RSK2 RSK3 RSK4 downstream members extracellular signal-regulated ERK/MAPK cascade humans Coffin-Lowry syndrome mental retardation growth deficits defects tonic regulation GPCRs G protein-coupled signalling immunoblotting | ||||
| 13300 |
Ro 31- |
113963-68-1 | ≥98% |
|
2009-07-28 | 3.809779005525 | ro-31-6045 | Bisindolylmaleimide V | PKC kinase inhibitors S6K mitogen-stimulated proteins p70 p85 protein kinases C | ||
| 13333 |
Ro 31- |
138516-31-1 | 98% |
|
2009-07-30 | 17.481026233698 | ro-31-7549-acetate | Bisindolylmaleimide VIII, acetate | PKC isozyme inhibitors phospholipases cells signalling signaling SH-SYSY neuroblastoma 125313-65-7 inhibits inhibitions | ||
| 13334 |
Ro 31- |
138489-18-6 | 98% |
|
2009-10-28 | 7.757419851919 | ro-31-8220-mesylate | Bisindolylmaleimide IX | bisindolylmaleimide inhibitor protein kinase C PKC PKC-α PKC-βI PKC-βII PKC-γ PKC-ε PKA CaM kinase II glycogen synthase kinase-3 GSK-3 Ro318220 GSK3 125314-64-9 Ro-31-8220 75-75-2 | ||
| 13343 |
RSC- |
337307-06-9 | ≥95% |
|
2010-02-15 | 61.004162062615 | rsc-3388 | cytosolic phospholipases A2 cPLA2 cPLA2α arachidonic acids eicosanoids platelet-activating factors PAF inhibitors inhibits inhibition inflammation dermatitis | |||
| 13067 | SB 203580 | 152121-47-6 | ≥98% |
|
2009-01-14 | 23.338839779005 | sb-203580 | RWJ 64809; PB 203580 | MAPKs signal transduction p38 kinases cytokines inflammation immune response PI3-kinase PDK1 apoptosis inhibitors inhibits inhibition sb203580 | ||
| 13344 | SB 203580 (hydrochloride) | 869185-85-3 | ≥98% |
|
2009-09-08 | 18.926298342541 | sb-203580-hydrochloride | PB 203580 (hydrochloride); RWJ 64809 (hydrochloride) | inhibitors inhibits inhibitions MAPK signal transduction p38 kinase PI3 PDK1 | ||
| 13336 | SB 225002 | 182498-32-4 | ≥95% |
|
2009-07-08 | 57.813314917128 | sb-225002 | CXCR2 IL-8RB IL-8 CXCL8 Gro-α CXCL1 inflammation chemokines neutrophils angiogenesis inhibitors colitis chemotaxis IL8 IL8RB Groα inhibition inhibits sb225002 | |||
| 10010247 | SB 415286 | 264218-23-7 | ≥98% |
|
2008-10-29 | 12.089189686924 | sb-415286 | GSK3 GSK-3 PI3K signaling PI3K signalling glycogen synthase inhibitors inhibits inhibition neuron survival glycogen synthesis Chang human liver cells line potent selective sb415286 | |||
| 13031 | SB 431542 | 301836-41-9 | ≥98% |
|
2009-08-10 | 38.333161179045 | sb-431542 | inhibitors inhibits inhibitions TGF-β1 TGFβ1 receptors ALK5 ALK4 ALK7 ALKs BMP ALK2 ALK3 ALK6 kinases Smad fibrosis cancers renewal embryonic stems cells induced pluripotent differentiation SB431542 | |||
| 10009557 |
SC- |
- | ≥98% |
|
2008-08-11 | 17.977569060773 | sc-1 | Pluripotin | stem cells embryonic ras signal transduction ERK1 ERK2 ERK-1 ERK-2 PI3-kinase differentiation self-renewal selfrenewal SC1 SC 1 | ||
| 10010267 |
SC- |
354812-17-2 | ≥98% |
|
2009-08-07 | 39.982154696132 | sc-514 | SC514 SC 514 inhibitors inhibits inhibitions IκB kinase IkB IKK2 NF-κB NFκB IL-1β IL1β genes expressions IL-6 IL6 IL-8 IL8 COX-2 COX2 iNOS LPS smooth muscles cells TLR2 TNF astrocytes | |||
| 10009312 |
SKF- |
130495-35-1 | >98% |
|
2007-01-19 | 14.202375690607 | skf-96365-hydrochloride | calcium antagonists voltage-gated inhibits inhibitors inhibition acetylcholine-induced depolarization smooth muscles platelets neutrophils SFK9635 Ach-induced HCl neurochemistry | |||
| 10007974 | SLF Exclusive | - | >98% |
|
✓ | 2006-04-14 | 39.773259668508 | slf | Synthetic Ligand of FKBP | FK-506 synthetic binding proteins FKBP12 ligands immunosuppressants inhibits calcium/calmodulin-dependent phosphatases calcineurins T-cells cell-permeable analogs homodimers heterodimers dimerization ligand-specific fusion signaling monomers 10-atoms linkers Fas | |
| 10012555 | Sodium Hydrogen Sulfide (hydrate) | 207683-19-0 | ≥65% |
|
2009-09-03 | 7.244880294659 | sodium-hydrogen-sulfide-hydrate | Sodium Hydrosulfide; NSC 158264; NaHS | hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 | ||
| 10010466 | SP 600125 | 129-56-6 | ≥98% |
|
2009-01-07 | 5.877348066298 | sp-600125 | 1PMV; Pyrazolanthrone; NSC 75890 | c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125 | ||
| 9000631 | Stearoyl Serotonin Exclusive New | 67964-87-8 | ≥98% |
|
✓ | 2010-05-18 | 0E-12 | stearoyl-serotonin | N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA | ||
| 13342 | SU 5416 | 204005-46-9 | ≥98% |
|
2009-07-16 | 52.371675874770 | su-5416 | VEGFR 2 Kinase Inhibitor; Semaxinib; Sugen 5416; NSC 696819 | inhibitors inhibits inhibition tyrosine kinases receptors vascular endothelial growth factor VDGF VEGFR-2 VEGFR2 VEGFR 2 Flk-1 Flk 1 Flk1 KDR cancers tumors vascularization PDGFR c-Kit cKit RET Flt-3 Flt3 Flt 3 ABL EGF FGF | ||
| 13338 | SU 6656 | 330161-87-0 | ≥95% |
|
2009-08-04 | 10.202058011049 | su-6656 | inhibitors Src kinases Src Yes Lyn Fyn cells growth development nervous system fibrosis cancers inhibits inhibition CNS SU6656 | |||
| 10007565 | Tetradecyl Phosphonate | 4671-75-4 | >98% |
|
2005-10-17 | 46.953667127072 | tetradecyl-phosphonate | pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter | |||
| 13237 | Thiamet G Exclusive | 1009816-48-1 | ≥97% |
|
✓ | 2009-06-25 | 19.227845303867 | thiamet-g | inhibitors inhibits inhibitions tau alzheimers disease O-GlcNAc OGlcNAc O-GlcNAcase OGlcNAcase O-GlcNAcylation OGlcNAcylation Thiamet-G | ||
| 10010237 | Triciribine | 35943-35-2 | >98% |
|
2007-09-11 | 22.686187845304 | triciribine | Tricyclic Nucleoside; NSC 154020 | Akt cancers inhibitors inhibition inhibits Akt-1 Akt1 Akt-2 Akt2 Akt-3 Akt3 PI3-kinase PI3kinase PI3K PI-3-kinase phosphorylation activation signalling pathway signaling | ||
| 70970 |
U- |
109511-58-2 | >98% |
|
2007-11-20 | 30.898634569850 | u-0126 | U0126 MAPK MAP Kinases inhibitors inhibits inhibition MEK MEK1 MEK2 signal transduction ATP adenosine triphosphate U 0126 | |||
| 10009152 | Valinomycin | 2001-95-8 | >95% |
|
2007-01-22 | 42.270966850828 | valinomycin | NSC 122023 | Ionophore potassium ion antibiotic apoptosis cyclododecadepesipeptide Streptomyces efflux phosphatidylserine membrane translocation caspase-3 activation | ||
| 13671 |
Wortmannin- |
- | ≥98% |
|
2010-05-11 | 0E-12 | wortmannin-rapamycin-conjugate | phosphoinositides 3-kinases PI3K mammalian targets mTOR cancers inhibitors inhibits inhibition complex 1 mTORC1 tumors bevacizumab VEGF colons A498 HT29 53123-88-9 sirolimus prodrug linkers links 19545-26-7 KY 12420 renal | |||
| 10008883 |
WST- |
- |
|
2006-09-07 | 33.206016837673 | wst-1-cell-proliferation-assay-kit | assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements cancers cell-based assay cell based assay cba | ||||
| 10010199 |
WST- |
- |
|
2007-09-11 | 60.442836095763 | wst-8-cell-proliferation-assay-kit | assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microwell plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba | ||||
| 13639 | WZ811 Exclusive New | 55778-02-4 | ≥95% |
|
✓ | 2010-03-22 | 123.014020871700 | wz811 | CXC chemokines receptors CXCR4 stromal cell-derived factor-1 SDF-1 CXCL12 hematopoietic stem cells chemotaxis lymphocytes growth metastasis cancers T cells HIV infection inhibitors antagonist cAMP Matrigel invasion breast cancer adenocarcinoma inhibition | ||
| 13596 | XAV939 Exclusive | 284028-89-3 | ≥98% |
|
✓ | 2009-12-03 | 50.151372256234 | xav939 | Wnt cancers β-catenin APC axin GSK3 poly-ADP-ribosylation tankyrases TNKS1 TNKS2 inhibitors inhibition inhibits | ||
| 10010200 | XTT Cell Proliferation Assay Kit | - |
|
2007-09-11 | 41.906003683241 | xtt-cell-proliferation-assay-kit | assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba | ||||
| 10005583 |
Y- |
129830-38-2 | >98% |
|
2007-11-29 | 49.029558011050 | y-27632-hydrochloride | Y27632 inhibitors inhibit inhibition Rho ROCK ROCK-II ROCKII PRK2 smooth muscle contraction cell adhesion signal transduction kinase phosphorylation HCl competative Y 27632 146986-50-7 | |||
| 13246 |
YM- |
223499-30-7 | ≥98% |
|
2009-11-16 | 5.585937500000 | ym-58483 | BTP 2 | calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT | ||
| 13665 | YS121 Exclusive New | 916482-17-2 | ≥98% |
|
✓ | 2010-04-02 | 15.062066298342 | ys121 | Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition inhibits PGs YS 121 YS-121 | ||
| 10010421 | Zaprinast | 37762-06-4 | ≥98% |
|
2008-09-18 | 9.154272559852 | zaprinast | 2-(o-Propoxyphenyl)-8-azapurin-6-one; M&B 22,948 | sildenafil viagra phophodiesterase cGMP PDE5 GRP35 inhibitors inhibits inhibition M&B 22948 55122-20-8 | ||
| 71800 |
(Z)- |
39025-23-5 | ≥98% |
|
2009-12-01 | 1.714984453480 | -z-guggulsterone | anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt | |||
| 10010367 | ZM 336372 | 208260-29-1 | >98% |
|
2008-01-09 | 3.300121546960 | zm-336372 | Raf-1 c-raf inhibitors inhibition inhibits cancers anti-cancer MEK 1/2 MAPK signals transductions proliferations cells cycles ERK1 ERK2 ERK1/2 ATP adenosine triphosphate signaling carcinoid tumor |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2010 Cayman Chemical Company
Quick Search